Onyx Pharmaceuticals IncNASDAQ:ONXX

Help
Symbol Lookup
    No Matches were found for
    Additional matches for ...
     
    Go
    OverviewChartsNewsFundamentalsEarningsReportsCalendarOptionsTechnical Insight

    Symbol Lookup

    Close

    Search Criteria

    Name or Symbol

    Security Type

    Fund Categories

    Market

    Expiration Filter

    Chain Type

    Submit
    Wednesday June 19, 2013 6:28 AM ET. Data delayed 15 minutes.
    88.80
    0.00 (0.00%)
    Price HistoryRefresh
    Bid/Lots
    84.00/1
    Ask/Lots
    88.80/0
    Open/Prev Close
    0.00/88.80
    Day Range
    -----
    52-Week Range
    43.73-101.57
    Vol/Avg Daily Vol
    0.0/876.7K

    ONXX Article

    Go

    Jun 14, 2013

    Critical Alerts For Anheuser-Busch InBev, GlaxoSmithKline, Capital One, Safeway, and Onyx Pharmaceuticals Released By InvestorsObserver
    9:31AM ET on Friday Jun 14, 2013 by PR Newswire
    Companies Mentioned: GSK, BUD, ONXX, SWY, COF

    InvestorsObserver issues critical PriceWatch Alerts for BUD, GSK, COF, SWY, and ONXX.

    (Photo: http://photos.prnewswire.com/prnh/20120712/CG39046)

    To see what our analysts have discovered about these stocks read the InvestorsObserv...

    Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
    8:00AM ET on Friday Jun 14, 2013 by PR Newswire
    Companies Mentioned: IMGN, ONXX, QCOR, ALXN, BMRN

    Today, Wall Street Reports announced new research reports highlighting Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Questcor Pharmaceuticals, Inc. (NASDAQ:...

    Jun 6, 2013

    Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
    4:00PM ET on Thursday Jun 06, 2013 by Marketwire
    Companies Mentioned: ONXX

    Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will present at two upcoming investor conferences in June and July.

    Goldman Sachs 34th Annual Global Healthcare Conference Onyx will present at the Goldman Sachs 34th An...

    Jun 3, 2013

    Onyx Pharmaceuticals and the UCSF Helen Diller Family Comprehensive Cancer Center Announce Oncology Innovation Alliance
    8:00AM ET on Monday Jun 03, 2013 by Marketwire
    Companies Mentioned: ONXX

    Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) and the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center today announced the formation of the Oncology Innovation Alliance (OIA), a public-private partnersh...

    Jun 2, 2013

    Phase 3 DECISION Trial Investigating the Use of Nexavar® (sorafenib) Demonstrated Significant Improvement in Progression-Free Survival in Patients with Radioactive Iodine-Refractory Differentiated Thyroid Cancer
    7:30AM ET on Sunday Jun 02, 2013 by PR Newswire
    Companies Mentioned: ONXX

    Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced positive results from the Phase 3 DECISION trial investigating the use of Nexavar® (sorafenib) tablets in patients with locally advanced or metastati...

    Bayer's Nexavar shown to delay thyroid cancer by 5 months
    7:30AM ET on Sunday Jun 02, 2013 by Thomson Reuters
    Companies Mentioned: ONXX

    FRANKFURT, June 2 (Reuters) - Bayer said on Sunday its cancer drug Nexavar was shown to delay progression of a difficult-to-treat type of thyroid canc...

    May 31, 2013

    Onyx Pharmaceuticals Announces Conference Call to Discuss Phase 3 DECISION Data at 2013 ASCO Annual Meeting
    4:00PM ET on Friday May 31, 2013 by Marketwire
    Companies Mentioned: ONXX

    Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will hold a conference call to discuss data presented at an ASCO plenary session from the DECISION study, a Phase 3 trial investigating the use of Nexavar(R) (sorafenib) tablets ...

    May 21, 2013

    Onyx Pharmaceuticals Announces Data Presentations at the 18th Congress of the European Hematology Association
    4:00PM ET on Tuesday May 21, 2013 by Marketwire
    Companies Mentioned: ONXX

    Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the upcoming presentation of data highlighting Kyprolis(R) (carfilzomib) for Injection, a second-generation proteasome inhibitor, and oprozomib, an oral proteasome inhibitor in early dev...

    K=Thousands, M=Millions, B=Billions, TTM=Trailing 12 Month, MRQ=Most Recent Quarter, FYR=Fiscal Year End, NM=Not Meaningful, NA=Not Available

    GAAP = Generally Accepted Accounting Principles used in Financial Statements issued by the company, Non-GAAP = Adjusted Operating Earnings or Revenue used in comparison to Analyst Estimates. Adjustments are typically one-time gains or losses

    6:28 AM June 19, 2013
    Copyright ©2013 TD Waterhouse Canada Inc. All rights reserved.
    Privacy Policy | Internet Security | Legal
    Quotes, News, and Fundamentals provided by
    View restrictions
    News provided by